Furthermore, when we stratified patients according to their SLEDAI score, we found that the levels of anti-PD-1 IgG in new-onset SLE patients with SLEDAI scores of 0–4 were significantly lower compared with patients with SLEDAI scores of 5–9 and >14. This evidence concerns the gene PDCD1 and systemic lupus erythematosus.